{"result": "(\"entity\"<|>MAGNESIUM<|>EVENT<|>Magnesium is a vital mineral in the body, playing a crucial role in various physiological functions, including muscle and nerve function, blood glucose control, and blood pressure regulation.)\n##\n(\"entity\"<|>POTASSIUM<|>EVENT<|>Potassium is an essential mineral that helps regulate fluid balance, muscle contractions, and nerve signals in the body.)\n##\n(\"entity\"<|>ACUTE PANCREATITIS<|>EVENT<|>Acute pancreatitis is a sudden inflammation of the pancreas that can lead to serious complications and is often associated with low intracellular magnesium levels.)\n##\n(\"entity\"<|>RENAL MAGNESIUM WASTING<|>EVENT<|>Renal magnesium wasting refers to the excessive loss of magnesium through urine, which can be associated with certain therapeutic agents and medical conditions.)\n##\n(\"entity\"<|>HYPERCALCEMIA<|>EVENT<|>Hypercalcemia is a condition characterized by elevated calcium levels in the blood, which can affect magnesium levels and overall health.)\n##\n(\"entity\"<|>HYPERPARATHYROIDISM<|>EVENT<|>Hyperparathyroidism is a condition where the parathyroid glands produce too much hormone, leading to elevated calcium levels and potential magnesium imbalance.)\n##\n(\"relationship\"<|>MAGNESIUM<|>HYPOPHOSPHATEMIA<|>Magnesium levels can influence phosphate metabolism, and imbalances may lead to hypophosphatemia<|>4)\n##\n(\"relationship\"<|>MAGNESIUM<|>HYPOMAGNESEMIA<|>Low magnesium levels can lead to hypomagnesemia, which is a direct relationship<|>8)\n##\n(\"relationship\"<|>POTASSIUM<|>MAGNESIUM<|>Potassium and magnesium levels are often interrelated in the body, affecting each other's balance<|>5)\n##\n(\"relationship\"<|>ACUTE PANCREATITIS<|>HYPOMAGNESEMIA<|>Acute pancreatitis can lead to low magnesium levels in patients<|>6)\n##\n(\"relationship\"<|>RENAL MAGNESIUM WASTING<|>HYPOMAGNESEMIA<|>Renal magnesium wasting is a common cause of hypomagnesemia<|>7)\n##\n(\"relationship\"<|>HYPERCALCEMIA<|>HYPOMAGNESEMIA<|>Hypercalcemia can lead to disturbances in magnesium levels, potentially causing hypomagnesemia<|>5)\n##\n(\"relationship\"<|>HYPERPARATHYROIDISM<|>HYPOMAGNESEMIA<|>Hyperparathyroidism can result in imbalances in magnesium levels, leading to hypomagnesemia<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . 2017;37(4):370-80.                               • Lajer H, Kristensen M, Hansen HH, Christensen S, Jonassen T, Daugaard G. Magnesium and potassium homeostasis during cisplatin\n         • Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, et al. Diagnosis, evaluation, and treatment            treatment. Cancer Chemother Pharmacol. 2005;55:231.\n           of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-42.                                             • Ryzen E, Rude RK. Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia. West J Med. 1990;152:145.\n                                                                                                                                            • Shah GM, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Miner Electrolyte Metab. 1991;17:58.\n                                                                                                                                            • Wong ET, Rude RK, Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients.\n                                                                                                                                              Am J Clin Pathol. 1983;79:348.\n     52  ¿Cuál de las siguientes circunstancias no se asocia a la aparición\n         de hipomagnesemia?\n         A. El síndrome de intestino corto.\n         B. La insuficiencia renal crónica.\n         C. El tratamiento con cisplatino.\n         D.   Todas las respuestas anteriores son causa de hipomagnesemia.\n\n\n\n484                                                                                                                                                                                                                                                                          485\n---\n     53  Respecto a la hipofosfatemia (señale la opción cierta):\n         A. Puede aparecer en el proceso de realimentación de un paciente en situación de\n             desnutrición severa.\n         B. La causa más habitual de hipofosfatemia es la realización de dietas bajas en fósforo.\n         C. La acidosis metabólica favorece la redistribución del fósforo, pasando al espacio\n             intracelular y por tanto disminuyendo los niveles plasmáticos.\n         D.  Todas las respuestas anteriores son ciertas.\n\n\n\n         COMENTARIO\n         La hipofosfatemia puede producirse por tres mecanismos:\n         1.  Disminución de la absorción intestinal: diarrea crónica con malabsorción (tránsito rá-\n             pido con menor absorción y pérdida por secreciones intestinales ricas en fósforo), uso\n             de antiácidos de manera crónica (secuestro intestinal por sales de calcio, magnesio o\n             aluminio).\n         2.  Incremento de la eliminación urinaria: hiperparatiroidismo primario o secundario, défi-\n             cit de vitamina D. Puede observarse igualmente en el síndrome de Fanconi.\n         3.  Movimiento agudo del fosfato extracelular al interior celular. El ejemplo típico sería la\n             realimentación del paciente con desnutrición severa (respuesta A correcta), el uso de in-\n             sulina en el tratamiento de una descompensación hiperglucémica o durante la alcalosis\n             respiratoria.\n         Referencias:\n         • Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012;60(4):655-61.Wong ET, Rude RK,\n           Singer FR, Shaw ST Jr. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol.\n           1983;79:348.\n\n\n\n486\n---\nR  Respuestas\n---\n                                                                                                   RESPUESTAS         R\n\n\n\n                                                                 Pregunta 13:  B  Pregunta 39:  A    Pregunta 65:  D\n     Módulo 1:     Hipófisis                                     Pregunta 14:  B  Pregunta 40:  D    Pregunta 66:  B\n     Pregunta 1:     A         Pregunta 22:  D  Pregunta 43:  C  Pregunta 15:  C  Pregunta 41:  B    Pregunta 67:  A\n     Pregunta 2:     B         Pregunta 23:  C  Pregunta 44:  D  Pregunta 16:  D  Pregunta 42:  B    Pregunta 68:  B\n     Pregunta 3:     C         Pregunta 24:  C  Pregunta 45:  B  Pregunta 17:  B  Pregunta 43:  C    Pregunta 69:  C\n     Pregunta 4:     A         Pregunta 25:  C  Pregunta 46:  A  Pregunta 18:  A  Pregunta 44:  A    Pregunta 70:  C\n     Pregunta 5:     C         Pregunta 26:  D  Pregunta 47:  A  Pregunta 19:  D  Pregunta 45:  A    Pregunta 71:  C\n     Pregunta 6:     D         Pregunta 27:  A  Pregunta 48:  C  Pregunta 20:  C  Pregunta\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>CISPLATIN<|>EVENT<|>Cisplatin is a chemotherapy drug used in the treatment of various cancers, which can lead to side effects such as hypomagnesemia.)\n##\n(\"entity\"<|>HYPOPHOSPHATEMIA<|>EVENT<|>Hypophosphatemia is a condition characterized by low levels of phosphate in the blood, which can occur due to various mechanisms including malnutrition and metabolic disorders.)\n##\n(\"entity\"<|>HYPOMAGNESEMIA<|>EVENT<|>Hypomagnesemia is a condition marked by low magnesium levels in the blood, often seen in hospitalized patients and can be caused by various medical conditions.)\n##\n(\"entity\"<|>FELSENFELD AJ<|>PERSON<|>Felsenfeld AJ is an author who has contributed to the medical literature on the treatment of hypophosphatemia.)\n##\n(\"entity\"<|>WONG ET<|>PERSON<|>Wong ET is an author who has researched the prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients.)\n##\n(\"relationship\"<|>CISPLATIN<|>HYPOMAGNESEMIA<|>Cisplatin treatment can lead to hypomagnesemia as a side effect<|>7)\n##\n(\"relationship\"<|>HYPOPHOSPHATEMIA<|>HYPOMAGNESEMIA<|>Both conditions can occur due to similar underlying mechanisms such as malnutrition and metabolic disorders<|>5)\n##\n(\"relationship\"<|>FELSENFELD AJ<|>HYPOPHOSPHATEMIA<|>Felsenfeld AJ has written about the treatment approaches for hypophosphatemia<|>6)\n##\n(\"relationship\"<|>WONG ET<|>HYPOMAGNESEMIA<|>Wong ET has conducted research on the prevalence of hypomagnesemia in hospitalized patients<|>6)\n<|COMPLETE|>"}]}